{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:52:41Z","timestamp":1791989561629,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.canlet.2023.216468","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T23:03:21Z","timestamp":1699311801000},"page":"216468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of T\u03b2RI expression"],"prefix":"10.1016","volume":"579","author":[{"given":"Massar","family":"Alsamraae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Costanzo-Garvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-6212","authenticated-orcid":false,"given":"Benjamin A.","family":"Teply","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7526-712X","authenticated-orcid":false,"given":"Gary","family":"Sommerville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary T.","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J.","family":"Dafferner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher Y.","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel W.","family":"Fallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7624-670X","authenticated-orcid":false,"given":"Tammy","family":"Kielian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7514-6686","authenticated-orcid":false,"given":"Heather","family":"Jensen-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0171-5430","authenticated-orcid":false,"given":"Edson I.","family":"deOliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8154-7670","authenticated-orcid":false,"given":"Ian A.","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"McVicar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Keeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9996-7419","authenticated-orcid":false,"given":"Leah M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2023.216468_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.canlet.2023.216468_bib2","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2023.216468_bib3","first-page":"135","article-title":"The American cancer society's facts & figures: 2020 edition","volume":"11","author":"Viale","year":"2020","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.canlet.2023.216468_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.seminoncol.2018.01.003","article-title":"The surgical management of prostate cancer","volume":"44","author":"Sebesta","year":"2017","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2023.216468_bib5","first-page":"1","article-title":"Metastatic castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy: treatment patterns from the PROXIMA prospective Registry","volume":"4","author":"Akaza","year":"2018","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.canlet.2023.216468_bib6","first-page":"1288","article-title":"NCCN guidelines(R) insights: prostate cancer, version 1.2023","volume":"20","author":"Schaeffer","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.canlet.2023.216468_bib7","first-page":"622","article-title":"The treatment of metastatic, hormone-sensitive prostatic carcinoma","volume":"119","author":"Merseburger","year":"2022","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.canlet.2023.216468_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/107327481502200114","article-title":"Current and emerging therapies for bone metastatic castration-resistant prostate cancer","volume":"22","author":"Frieling","year":"2015","journal-title":"Cancer Control"},{"key":"10.1016\/j.canlet.2023.216468_bib9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10555-014-9494-4","article-title":"Integrating new discoveries into the \"vicious cycle\" paradigm of prostate to bone metastases","volume":"33","author":"Cook","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2023.216468_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40880-019-0425-1","article-title":"Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer","volume":"39","author":"Zhang","year":"2019","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2023.216468_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10555-021-09965-3","article-title":"Emerging roles for myeloid immune cells in bone metastasis","volume":"40","author":"Alsamraae","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2023.216468_bib12","first-page":"311","article-title":"Bone marrow cell differential counts obtained by multidimensional flow cytometry","volume":"18","author":"Terstappen","year":"1992","journal-title":"Blood Cell"},{"key":"10.1016\/j.canlet.2023.216468_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nmeth.3322","article-title":"Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes","volume":"12","author":"Hasenberg","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.canlet.2023.216468_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220011","article-title":"Neutrophil phenotypes and functions in cancer: a consensus statement","volume":"219","author":"Quail","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2023.216468_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.trecan.2016.12.006","article-title":"Mouse versus human neutrophils in cancer: a major knowledge gap","volume":"3","author":"Eruslanov","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2023.216468_bib16","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201803","article-title":"Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice","volume":"218","author":"Veglia","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2023.216468_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2023.216468_bib18","doi-asserted-by":"crossref","DOI":"10.4161\/15384101.2014.950163","article-title":"Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells","volume":"3","author":"Yan","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2023.216468_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12859-018-2139-9","article-title":"VIPER: visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis","volume":"19","author":"Cornwell","year":"2018","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.canlet.2023.216468_bib20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/andr.12213","article-title":"Elucidation of the mechanism of suppressed steroidogenesis during androgen deprivation therapy of prostate cancer patients using a mouse model","volume":"4","author":"Taniguchi","year":"2016","journal-title":"Andrology"},{"key":"10.1016\/j.canlet.2023.216468_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep26220","article-title":"Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-\/-) mice","volume":"6","author":"Knutsson","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2023.216468_bib22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","article-title":"Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies","volume":"18","author":"Cupp","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.canlet.2023.216468_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2018.11.013","article-title":"6-Phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3 and 4: a pair of valves for fine-tuning of glucose metabolism in human cancer","volume":"20","author":"Yi","year":"2019","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.canlet.2023.216468_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10585-022-10170-x","article-title":"Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils","volume":"39","author":"Costanzo-Garvey","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2023.216468_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.smim.2017.12.004","article-title":"Their biological role and interaction with stromal cells","volume":"35","author":"Zhou","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.canlet.2023.216468_bib26","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2023.216468_bib27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2016-04-713206","article-title":"Mature CD10(+) and immature CD10(-) neutrophils present in G-CSF-treated donors display opposite effects on T cells","volume":"129","author":"Marini","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2023.216468_bib28","first-page":"16","article-title":"Establishment and characterization of a human prostatic carcinoma cell line (PC-3)","volume":"17","author":"Kaighn","year":"1979","journal-title":"Invest. Urol."},{"key":"10.1016\/j.canlet.2023.216468_bib29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z","article-title":"Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID\/bg mice using LNCaP and lineage-derived metastatic sublines","volume":"77","author":"Wu","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216468_bib30","first-page":"1809","article-title":"LNCaP model of human prostatic carcinoma","volume":"43","author":"Horoszewicz","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216468_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00262-020-02527-6","article-title":"Neutrophils are mediators of metastatic prostate cancer progression in bone","volume":"69","author":"Costanzo-Garvey","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2023.216468_bib32","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.20082521","article-title":"Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor","volume":"206","author":"Chuang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2023.216468_bib33","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajpath.2012.07.008","article-title":"Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice","volume":"181","author":"Lai","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2023.216468_bib34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2023.216468_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1470-2045(17)30906-3","article-title":"Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study","volume":"19","author":"Teply","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216468_bib36","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/pros.21196","article-title":"Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen\/ablation in men with castration resistant prostate cancer","volume":"70","author":"Denmeade","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2023.216468_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2567.2008.02950.x","article-title":"Neutrophil mobilization and clearance in the bone marrow","volume":"125","author":"Furze","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2023.216468_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1100585","article-title":"Osteoid cell-derived chemokines drive bone-metastatic prostate cancer","volume":"13","author":"Johnson","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2023.216468_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/DDDT.S15850","article-title":"Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer","volume":"6","author":"Rehman","year":"2012","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.canlet.2023.216468_bib40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2023.216468_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0736-5748(94)00061-7","article-title":"Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10","volume":"13","author":"Benveniste","year":"1995","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.canlet.2023.216468_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5607\/en.2012.21.4.151","article-title":"Role of TGF-beta in survival of phagocytizing microglia: autocrine suppression of TNF-alpha production and oxidative stress","volume":"21","author":"Ryu","year":"2012","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.canlet.2023.216468_bib43","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2012-01-404046","article-title":"Ly6G ligation blocks recruitment of neutrophils via a beta2-integrin-dependent mechanism","volume":"120","author":"Wang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2023.216468_bib44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41590-023-01452-x","article-title":"Strategies of neutrophil diversification","volume":"24","author":"Palomino-Segura","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2023.216468_bib45","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2020.10.003","article-title":"Co-Option of neutrophil fates by tissue environments","volume":"183","author":"Ballesteros","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216468_bib46","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/s41467-021-22973-9","article-title":"The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments","volume":"12","author":"Grieshaber-Bouyer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216468_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/JLB.1CE0720-378R","article-title":"Emerging neutrophil plasticity: terminally differentiated cells no more","volume":"109","author":"Sumagin","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.canlet.2023.216468_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12020444","article-title":"Neutrophil activation\/maturation markers in chronic heart failure with reduced ejection fraction","volume":"12","author":"Prausmuller","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.canlet.2023.216468_bib49","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses","volume":"23","author":"Guo","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2023.216468_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.canlet.2023.216468_bib51","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.bbmt.2019.08.012","article-title":"Comparison of high doses of total body irradiation in myeloablative conditioning before hematopoietic cell transplantation","volume":"25","author":"Sabloff","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.canlet.2023.216468_bib52","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0022-5347(17)35251-5","article-title":"Severe reversible neutropenia following treatment of prostate cancer with flutamide","volume":"151","author":"McDonnell","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2023.216468_bib53","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1038\/s41467-018-07505-2","article-title":"Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression","volume":"9","author":"Rice","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216468_bib54","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/0008-5472.CAN-13-2652","article-title":"An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer","volume":"74","author":"Araujo","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216468_bib55","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1038\/s41388-019-0913-4","article-title":"Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis","volume":"38","author":"Cook","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2023.216468_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/srep29384","article-title":"Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer","volume":"6","author":"Cook","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2023.216468_bib57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2023.216468_bib58","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1158\/1078-0432.CCR-11-3224","article-title":"Molecular pathways: targeting the TGF-beta pathway for cancer therapy","volume":"18","author":"Smith","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216468_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102984","article-title":"Inflammation as a driver of prostate cancer metastasis and therapeutic resistance","volume":"12","author":"Archer","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2023.216468_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jcb.21255","article-title":"A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling","volume":"101","author":"Brown","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2023.216468_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/pros.23708","article-title":"TGF-beta receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer","volume":"79","author":"Paller","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2023.216468_bib62","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41591-021-01244-6","article-title":"Transcriptional mediators of treatment resistance in lethal prostate cancer","volume":"27","author":"He","year":"2021","journal-title":"Nat. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523004196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523004196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:13:14Z","timestamp":1759594394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523004196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":62,"alternative-id":["S0304383523004196"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216468","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of T\u03b2RI expression","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216468"}}